XPhyto Therapeutics Corporation
XPhyto - CBD Oral/Sublingual Strip
Clinical studies are planned in 2021 to demonstrate the efficient sublingual delivery of CBD for treatment-resistant Epilepsy.
Clinical studies are planned in 2021 to demonstrate the efficient sublingual delivery of CBD for treatment-resistant Epilepsy.